Mohawk Tribe Questions Patent Board's Impartiality In Restasis Case
Executive Summary
Supreme Court's concern about 'panel stacking' reflected in Mohawk Tribe's request to know the identity of PTAB members deciding its request to toss inter partes review.
You may also be interested in...
Mohawk Tribe Is Not Immune To IPR (And Allergan Really Owns Restasis Patents Anyway) PTAB Decrees
Allergan's novel tactic to derail inter partes review of Restasis patents ends for now as Patent Trial and Appeal Board denies Tribe's request to terminate proceeding; Board sets June 6 deadline for final written decision on IPR petition.
Allergan Loses Another Battle, But War To Block Restasis Generics Continues
US FDA rejects Allergan's third citizen petition seeking to require comparative clinical trials of generic versions of its dry eye medicine; company appeals patent invalidity ruling and PTAB admonishes Mohawk Tribe for its actions in IPR proceeding.
Allergan Loses Another Battle, But War To Block Restasis Generics Continues
US FDA rejects Allergan's third citizen petition seeking to require comparative clinical trials of generic versions of its dry eye medicine; company appeals patent invalidity ruling and PTAB admonishes Mohawk Tribe for its actions in IPR proceeding.